START FREE TRIAL
Home Healthcare HCA Healthcare

HCA Healthcare

$19.00

SKU: HCA-1 Category:

Description

HCA Healthcare’s $650 Million Medicaid Threat: Can Hospital Profits Survive the Squeeze?

 

HCA Healthcare, Inc. reported a third-quarter 2026 performance characterized by continued volume growth and solid financial results, albeit amid ongoing challenges related to payer mix shifts and surgical volume pressures. Adjusted admissions increased 3% on a same-facility basis, marking the company’s 22nd consecutive quarter of volume growth. Insured volumes exhibited a stronger increase compared to the first half of 2026, supporting revenue growth per adjusted admission in the insured segment, excluding supplemental payments. However, a notable decline in patients formerly covered by health insurance exchanges (HIX), migrating almost directly to uninsured status, negatively impacted the payer mix and adjusted EBITDA by approximately $400 million in the quarter. This trend contributed to an unfavorable adjusted EBITDA effect slightly exceeding prior guidance for the full year.